Tomorrow is the start of the 2024 #ISPORannual event! DCRI PrefER presenters, panelists, discussants, and moderators include Juan Marcos Gonzalez, Reed Johnson, Shelby Reed, Alicja Mastylak, and Jessie Sutphin. Stay tuned for the full session schedule!

Hand grip strength (HGS) is an informative biomarker – yet its value outside of older adult populations is unexplored. DCRI’s Adam Goode and Verily examined how HGS can identify clinical characteristics and conditions in other demographic groups: nature.com/articles/s4159…

If you have #Afib , your doctor may recommend cardioversion treatment, which is “very much like rebooting a computer that has crashed,” says DCRI’s Jonathan Piccini, MD, MHS. Learn more about what he and other experts have to say about this treatment option: healthcentral.com/article/electr…

Dr. Stephen Balevic and colleagues at the DCRI recently conducted a secondary analysis of the ACTIV-1 IM clinical trial, finding reduced mortality in hospitalized adults with severe COVID-19 who achieved higher exposures of abatacept. Learn more: jamanetwork.com/journals/jaman…

The DCRI, together with Duke-Margolis and Eli Lilly and Company, is working to establish a platform for characterizing obesity management patterns and treatment responses while addressing barriers to clinical trials. Learn more: dcri.org/news/new-partn…

At #ACC24 , DCRI’s Pamela S Douglas joined Healio to discuss the new Project REACH initiative, which seeks to increase diversity and equity in clinical trial leadership. Watch her video interview here to learn more: healio.com/news/cardiolog…

In a new review for JACC Journals, DCRI Fellow Mark Kittipibul MD and Robert Mentz, MD discuss the benefits of SGLT2i, the associated risk of GU infections, and practice considerations for patients with cardiovascular disease: sciencedirect.com/science/articl…

The DCRI is excited to partner with Saghmos Therapeutics to optimize and plan the operationalization of their Phase 3 study for its cardio-renal metabolic modulator ST-62516. Learn more here: dcri.org/news/saghmos-t…

What is the future of moving #evidencebased therapies into action for #CKM disease? Broad #dissemination of results and training the next generation of #knowledgetranslation scientists. Be a part of the #ImpSci conversation. #CVD Read more: duke.is/imp-summit

DCRI faculty & fellows shared new insights and expertise on the latest in cardiology research as part of the over 100 late-breaking studies, presentations, panels, and posters at #ACC24 . Get caught up on some of the top stories from the event here: dcri.org/news/acc-2024-…

Several heart conditions like HOCM can be inherited – yet many are unaware of their family’s heart health history. DCRI’s Svati Shah shares helpful tips on to talk to your family about heart health, including what questions to ask and who to talk to: time.com/6965727/how-to…

A newly-published paper featuring DCRI authors Nishant Shah, MD, Neha Pagidipati, and Svati Shah explores how comprehensive health parameter associate with BMI, offering a deeper understanding of cardiovascular health across BMI. pubmed.ncbi.nlm.nih.gov/38550633/

Hospital costs for those with #HFrEF tend to be high – yet the factors that contribute to these costs vary. DCRI Fellow Mark Kittipibul MD sat down with HCPLive at #ACC24 to discuss the GWTG-HF registry, and how to reduce HF-related costs: hcplive.com/view/understan…

That wraps up #ACC24 ! Stayed tuned for our event recap, where we’ll cover the great findings shared by those at the DCRI.

DCRI's Robert Mentz, MD's focus on 'beans' at #ACC24 highlighted how GDMT, including RAASi and SGLT2, can potentially reduce CV and renal events and lead to fewer discontinuations of other therapies. For patients with CKD, GDMT, this may result in an even greater benefit.

Shelby Reed’s presentation on the health economics of lipid-lowering medications will begin in 15 minutes at #ACC24 .

DCRI’s Larry Jackson will present and serving as a panelist at the #ACC24 session “Sharing the Sandbox: The Importance of Collaboration Between EP and HF” in 15 minutes.

DCRI's Jennifer Rymer and Schuyler Jones, along with former DCRI member Sunil V. Rao, took a deep dive into the ACS toolbox at #ACC24 today, where they examined guidelines, proven and potential therapies, and opportunities to tailor approaches to each patient's unique needs.